Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Ranpak Holdings Corp.
SIC 2670 · Converted Paper & Paperboard Prods (No Containers/Boxes)
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Ranpak Holdings Corp.
SIC 2670 · Converted Paper & Paperboard Prods (No Containers/Boxes)
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Ranpak Holdings Corp.
SIC 2670 · Converted Paper & Paperboard Prods (No Containers/Boxes)
Notes
Support
about
terms
$
PACK
Ranpak Holdings Corp.
CIK:
0001712463
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Millions
3 Months Ended
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]
Net product revenue
$ 86.4
$ 77.8
$ 168.2
$ 155.4
Machine lease revenue
18.8
14.5
38.2
28.1
Net revenue
105.2
92.3
206.4
183.5
Cost of product sales
64.4
56.0
123.9
110.8
Cost of leased machines
6.3
7.4
13.1
12.9
Gross profit
34.5
28.9
69.4
59.8
Selling, general and administrative expenses
27.6
28.8
56.8
57.7
Depreciation and amortization expense
8.6
8.8
17.6
17.8
Other operating expense, net
0.7
1.0
1.2
2.0
Loss from operations
(2.4)
(9.7)
(6.2)
(17.7)
Interest expense
8.1
8.3
16.7
17.0
Foreign currency loss (gain)
0.2
(2.6)
1.5
(5.2)
Other non-operating expense (income), net
0.1
(5.9)
0.1
(5.9)
Loss before income tax benefit
(10.8)
(9.5)
(24.5)
(23.6)
Income tax benefit
(2.9)
(2.0)
(6.4)
(5.2)
Net loss
$ (7.9)
$ (7.5)
$ (18.1)
$ (18.4)
Basic loss per share (in usd per share)
$ (0.09)
$ (0.09)
$ (0.21)
$ (0.22)
Diluted loss per share (in usd per share)
$ (0.09)
$ (0.09)
$ (0.21)
$ (0.22)
Weighted average number of shares outstanding – basic (in shares)
85,632,691
84,274,167
85,393,528
83,987,624
Weighted average number of shares outstanding – diluted (in shares)
85,632,691
84,274,167
85,393,528
83,987,624
Other comprehensive income (loss), before tax
Foreign currency translation adjustments
$ 0.7
$ (4.6)
$ (0.6)
$ (7.2)
Cross-currency swap adjustments
0.4
(0.6)
0.0
(1.2)
Total other comprehensive income (loss), before tax
1.1
(5.2)
(0.6)
(8.4)
Provision (benefit) for income taxes related to other comprehensive income (loss)
0.5
(4.6)
1.1
(7.0)
Total other comprehensive income (loss), net of tax
0.6
(0.6)
(1.7)
(1.4)
Comprehensive loss, net of tax
$ (7.3)
$ (8.1)
$ (19.8)
$ (19.8)
v3.26.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows from Operating Activities
Net loss
$ (18.1)
$ (18.4)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization
32.6
31.9
Amortization of deferred financing costs
0.7
0.6
(Gain) Loss on disposal of property, plant, and equipment
(0.4)
0.2
Deferred income taxes
(2.6)
(1.8)
Foreign currency loss (gain)
1.5
(5.2)
Stock-based compensation expense
2.5
4.1
Provision for common stock warrants
3.4
2.0
Amortization of cloud-based software implementation costs
2.2
1.9
Unrealized gain on strategic investments
0.0
(5.8)
Changes in operating assets and liabilities:
Accounts receivable
(3.1)
1.2
Inventories
(2.5)
(15.0)
Income tax receivable
(4.4)
(4.0)
Prepaid expenses and other current assets
(2.2)
(4.6)
Accounts payable
0.8
5.2
Accrued liabilities and other
(0.6)
2.6
Change in other assets and liabilities
(2.7)
0.2
Net cash provided by (used in) operating activities
7.1
(4.9)
Cash Flows from Investing Activities
Purchases of converter equipment
(11.3)
(15.2)
Purchases of other property, plant, and equipment
(3.6)
(2.1)
Cash paid for strategic investments
(10.0)
(2.5)
Net cash used in investing activities
(24.9)
(19.8)
Cash Flows from Financing Activities
Principal payments on term loans
(2.1)
(2.1)
Proceeds from financing arrangements
3.8
0.0
Payments on financing arrangements
(1.3)
(0.4)
Payments on finance lease liabilities
(0.9)
(1.5)
Other financing activities, net
(0.6)
(0.9)
Net cash used in financing activities
(1.1)
(4.9)
Effect of Exchange Rate Changes on Cash and Cash Equivalents
(0.9)
2.7
Net Decrease in Cash and Cash Equivalents
(19.8)
(26.9)
Cash and Cash Equivalents, beginning of period
63.0
76.1
Cash and Cash Equivalents, end of period
$ 43.2
$ 49.2
v3.26.1
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Current assets
Cash and cash equivalents
$ 43.2
$ 63.0
Accounts receivable, net
49.4
47.7
Inventories
32.7
30.6
Income tax receivable
6.2
1.9
Prepaid expenses and other current assets
14.0
10.6
Total current assets
145.5
153.8
Property, plant and equipment, net
131.6
138.7
Operating lease right-of-use assets, net
21.8
24.0
Goodwill
454.0
457.2
Intangible assets, net
275.6
291.8
Deferred tax assets
0.4
0.4
Other assets
67.8
59.0
Total assets
1,096.7
1,124.9
Current liabilities
Accounts payable
36.5
36.7
Accrued liabilities and other
22.9
23.9
Current portion of long-term debt
6.8
5.5
Operating lease liabilities, current
3.5
3.9
Deferred revenue
11.6
14.0
Total current liabilities
81.3
84.0
Long-term debt
395.8
396.4
Deferred tax liabilities
48.8
50.7
Derivative instruments
27.5
33.4
Operating lease liabilities, non-current
22.1
24.2
Other liabilities
1.3
1.3
Total liabilities
576.8
590.0
Commitments and contingencies – Note 13
Shareholders’ equity
Class A common stock, $0.0001 par, 200,000,000 shares authorized at June 30, 2026 and December 31, 2025; shares issued and outstanding: 85,750,150 and 84,385,870 at June 30, 2026 and December 31, 2025, respectively
0.0
0.0
Additional paid-in capital
727.1
722.3
Accumulated deficit
(201.7)
(183.6)
Accumulated other comprehensive loss
(5.5)
(3.8)
Total shareholders’ equity
519.9
534.9
Total liabilities and shareholders’ equity
$ 1,096.7
$ 1,124.9